Enanta Pharmaceuticals Inc Logo Image

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc has reached its limit for report views.

Please check back to see if Enanta Pharmaceuticals Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report, Interactive Annual Report and Form 10K

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Enanta Pharmaceuticals Inc
  • Enanta Pharmaceuticals Inc
  • Enanta Pharmaceuticals Inc

About Enanta Pharmaceuticals Inc

51-200 Employees
Based in Watertown, Massachusetts

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States. Its product portfolio includes ABT-450, a protease inhibitor that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV); ABT-493, a next-generation protease inhibitor for HCV infection; EDP-239, an NS5A inhibitor for HCV infection; Cyclophilin inhibitor, which are in preclinical development stage for HCV infection treatment; and Nucleotide Polymerase inhibitor program for HCV infection.

Ticker:
ENTA
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol